10-Q · May 13, 2026
Nakamoto Inc. reported a significant improvement in Q4 2026, achieving EPS of $0.07 and revenue of $444,924, both exceeding expectations. Despite these gains, the company experienced large operational losses driven by a…
Earnings analysis · 10-Q
NAKA earnings analysis
Filed August 13, 2026 · Our reading of the company's report
The latest report
The provided 10-Q extract does not include income-statement, balance-sheet, segment, or cash-flow data, so revenue, margins, EPS, liquidity balances, and free cash flow cannot be assessed. The filing highlights restored…
Read full summary
The provided 10-Q extract does not include income-statement, balance-sheet, segment, or cash-flow data, so revenue, margins, EPS, liquidity balances, and free cash flow cannot be assessed. The filing highlights restored Nasdaq compliance at a $5.04 closing bid price and a new $25.0 million repurchase authorization. However, disclosure controls remained ineffective as of June 30, 2026 due to a material weakness, while repurchases could reduce liquidity and renewed bid-price noncompliance could threaten listing status.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Nasdaq compliance restored
The company regained Nasdaq minimum-bid-price compliance on June 9, 2026 following a 1-for-40 reverse stock split on May 22, 2026; the closing bid price was $5.04 as of August 10, 2026.
-
New $25 million buyback authorization
The board authorized the 2026 Repurchase Program for up to $25.0 million through December 31, 2026. No shares were repurchased under the program as of June 30, 2026, leaving the full $25.0 million available.
-
Prior buyback completed
The prior 2025 Repurchase Program ended January 31, 2026 after the company repurchased 58,305 shares for $0.9 million.
What to watch
-
Material weakness in internal controls
The company disclosed that its disclosure controls and procedures were not effective as of June 30, 2026 because of a material weakness in internal control over financial reporting. Management also stated there were no changes during the quarter that materially affected or were reasonably likely to materially affect internal control.
-
Buyback may weaken liquidity
The $25.0 million 2026 Repurchase Program could reduce cash reserves and resources available for collateral obligations under the June Loan. The program expires December 31, 2026 and had not repurchased any shares as of June 30, 2026.
-
Renewed delisting risk
Nasdaq’s minimum bid-price requirement is $1.00 per share; although the company was at $5.04 as of August 10, 2026, another failure could result in a Staff Delisting Determination because the May 22, 2026 reverse split occurred within the one-year look-back period. An additional reverse split of 1-for-6.25 or greater during the applicable two-year period would bring the cumulative ratio to at least 250-to-1.
Management's outlook
The provided 10-Q text does not disclose quantitative revenue or EPS guidance, and no change to prior guidance is stated.
Earlier filings 4
10-K · March 30, 2026
Nakamoto Inc. has successfully transitioned from a healthcare operation to focusing on Bitcoin treasury management following its merger with Nakamoto Holdings. Despite significant losses reported due to the decline in…
10-Q · November 19, 2025
Kindly MD, Inc. (NAKA) faced substantial financial challenges in Q3 2025, reporting a significant decrease in revenue and a sharp increase in net loss. Revenue declined 40.1% year-over-year to $388,209 due to decreased…
10-Q · August 5, 2025
NAKA reported a significant revenue decline of 36.1% year-over-year, totaling $408,527 for Q2 2025. Operating expenses surged by 67.0%, leading to a net loss of $2,413,787, which represents a 83.7% increase in losses…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.